Riskpilot← Back to searchSign inGet full accessWarOnCancer AB
ABBankruptOrg 5591191555Data processing, hosting and related activities · NACE 6311Est. 20170 employees
Revenue 2021
SEK 450K
+1352% vs 2020
EBITDA margin
-3979.8%
-34% vs 2020
Equity ratio
94.2%
Financial strength
Net profit 2021
SEK -17,9M
-35% vs 2020
| Revenue | SEK 450K | +1352% |
| EBITDA | SEK -17,9M | -34% |
| Net profit | SEK -17,9M | -35% |
| Total assets | SEK 30,8M | +193% |
| Equity | SEK 29M | +220% |
| Employees | 0 | — |
Legal name
WarOnCancer AB
Org number
5591191555
Legal form
Aktiebolag
NACE code
6311 · Data processing, hosting and related activities
Founded
12 juli 2017
Share capital
SEK 70 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2021-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Styrelsen ska bestå av 2 styrelseledamöter och 1 styrelsesuppleant.
Company purpose
Bolaget ska utveckla och bedriva en social plattform och bloggportal på internet samt bedriva därmed förenlig verksamhet. Bolaget ska även bedriva handel med smycken, kläder och andra dagligvaruartiklar samt bedriva därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Revenue | 2 196 | 354 | 31 | 450 |
| Staff expenses | — | — | — | — |
| EBITDA | −272 | −8 281 | −13 320 | −17 909 |
| Depreciation & amort. | −0 | −2 | −0 | −22 |
| EBIT | −272 | −8 283 | −13 320 | −17 931 |
| Net financials | — | −3 | −1 | −4 |
| Profit before tax | −272 | −8 286 | −13 322 | −17 935 |
| Tax | −0 | −0 | −0 | −0 |
| Net profit | −272 | −8 286 | −13 322 | −17 935 |
| Item | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|
| Total assets | 9 313 | 1 627 | 10 511 | 30 795 |
| Equity | 8 860 | 766 | 9 061 | 29 024 |
| Long-term debt | 0 | 38 | 0 | 0 |
| Short-term debt | 453 | 823 | 1 450 | 1 771 |
| Total debt | 453 | 861 | 1 450 | 1 771 |
EBITDA margin
-3979.8%
This company
15.8%
Market median
-25289% vs market
20182021
Equity ratio
94.2%
This company
38.2%
Market median
+147% vs market
20182021
Return on equity
-61.8%
This company
18.4%
Market median
-436% vs market
20182021
Net profit margin
-3985.6%
This company
8.1%
Market median
-49305% vs market
20182021
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20182021
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
20182021
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-07-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
DT Chief Auditor | Chief Auditor | 2021 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2021 | |
| Chairman | 2022 | |
| Former (2) | ||
| Chairman | 2021 – 2022 | |
| Chairman | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of WarOnCancer AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Dan Tobias Holmer Stråle | Chief Auditor | 0 companies |
| Viktor Rune Löfgren | Deputy Board Member | 0 companies |
| Moha Bensofia Gurgi | Chairman | 0 companies |
| Gustaf Sebastian Robert Hermelin | Chairman | 0 companies |
| Fabian Arthur Bolin | Chairman | 0 companies |